Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

GnRH pharmaccine reduces testosterone to castration levels

April 22, 1999

Small peptide from Angstrom highly active against human breast tumor xenografts

April 21, 1999

Sanofi and Lilly to jointly develop oxaliplatin in U.S.

April 21, 1999

SQ-885: a specific angiogenesis inhibitor and integrin antagonist

April 21, 1999

Immunomedics clones RNase and prepares RNase-containing anticancer fusion protein

April 21, 1999

Targretin as novel therapy for refractory breast cancer: preclinical studies

April 21, 1999

Encore begins phase II trials in prostate cancer patients of its lead product

April 21, 1999

Selective inhibitors of VEGF and FGF tyrosine kinase reported by Zeneca

April 21, 1999

AACR news: squalamine evaluated for activity in prostate and lung cancer models

April 20, 1999

Potent and long-lasting GnRH antagonist presented by Ferring

April 20, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.